At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,010 enrolled
Drug / intervention
plavix +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Safety, Benefits and Complications of Long-term Dual Antiplatelet Therapy in Patients With Angioplasty
In Brief
A clinical study evaluating plavix for Percutaneous Coronary Intervention. Completed, enrolled 1,010 participants.
Detailed Summary
1010 patients post stenting were enrolled to receive Plavix more than 12 months and less than that and rate of bleeding, complication and major cardiovascular adverse events ( MACE) were compared to evaluate safety and feasibility of long term Plavix therapy post stenting.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPercutaneous Coronary Intervention
Countries--
CollaboratorsBaqiyatallah Medical Sciences University
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2012
Primary CompletionSep 2014
Study CompletionOct 2014
First PostedDec 2014
TodayJul 2026
First PostedDec 30, 2014
Enrollment StartOct 1, 2012
Primary CompletionSep 1, 2014
Study CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 11.5 years ago
Interventions
plavixdrug
taking plavix more than 12 months
plavixdrug
taking plavix less than 12 months